All Stories

  1. A comprehensive method for modeling and simulating ion exchange chromatography of complex mixtures
  2. Peptide linker increased the stability of pneumococcal fusion protein vaccine candidate
  3. Pneumococcal Surface Protein A-Hybrid Nanoparticles Protect Mice from Lethal Challenge after Mucosal Immunization Targeting the Lungs
  4. ClearColi as a platform for untagged pneumococcal surface protein A production: cultivation strategy, bioreactor culture, and purification
  5. Robust Immune Response Induced by Schistosoma mansoni TSP-2 Antigen Coupled to Bacterial Outer Membrane Vesicles
  6. Optimization of Expression and Purification of Schistosoma mansoni Antigens in Fusion with Rhizavidin
  7. Strategies for the Production of Soluble Interferon-Alpha Consensus and Potential Application in Arboviruses and SARS-CoV-2
  8. High stabilization and hyperactivation of a Recombinant β-Xylosidase through Immobilization Strategies
  9. Evaluation of polymer choice on immunogenicity of chitosan coated PLGA NPs with surface-adsorbed pneumococcal protein antigen PspA4Pro
  10. Development of recombinant human granulocyte colony-stimulating factor (nartograstim) production process in Escherichia coli compatible with industrial scale and with no antibiotics in the culture medium
  11. Anti-Flavivirus Vaccines: Review of the Present Situation and Perspectives of Subunit Vaccines Produced in Escherichia coli
  12. Cost analysis based on bioreactor cultivation conditions: Production of a soluble recombinant protein using Escherichia coli BL21(DE3)
  13. Improvement of the production process for a new vaccine against pneumococcal diseases
  14. Modeling and simulation of anion exchange chromatography for purification of proteins in complex mixtures
  15. Optimization and scale-up production of Zika virus ΔNS1 in Escherichia coli: application of Response Surface Methodology
  16. Progress in mucosal immunization for protection against pneumococcal pneumonia
  17. Children as curators: how to incorporate young visitors’ voices into the elaboration and evaluation of a microbiology exhibition
  18. A new vector for heterologous gene expression in Escherichia coli with increased stability in the absence of antibiotic
  19. Learning about Microorganisms in Childhood: Four- to Six-Year-Old Children’s Voice in Kindergartens and Museums
  20. Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection
  21. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies
  22. IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine
  23. Production and purification of an untagged recombinant pneumococcal surface protein A (PspA4Pro) with high-purity and low endotoxin content
  24. DEVELOPMENT OF A NEW PROCESS FOR PURIFICATION OF CAPSULAR POLYSACCHARIDE FROM Streptococcus pneumoniae SEROTYPE 14
  25. Recombinant protein production by engineered Escherichia coli in a pressurized airlift bioreactor: A techno-economic analysis
  26. ON-LINE MONITORING OF BIOMASS CONCENTRATION BASED ON A CAPACITANCE SENSOR: ASSESSING THE METHODOLOGY FOR DIFFERENT BACTERIA AND YEAST HIGH CELL DENSITY FED-BATCH CULTURES
  27. Pulmonary dry powder vaccine of pneumococcal antigen loaded nanoparticles
  28. Capsular polysaccharide production by Streptococcus pneumoniae serotype 1: from strain selection to fed-batch cultivation
  29. PRODUÇÃO DE UMA MOLÉCULA RECOMBINANTE HÍBRIDA DE DUAS PROTEÍNAS DE Streptococcus pneumoniae: PspA94-PdT
  30. Improved capsular polysaccharide production by Streptococcus pneumoniae serotype 14 using continuous cultivation
  31. A supervision and control tool based on artificial intelligence for high cell density cultivations
  32. Development of a whole cell pneumococcal vaccine: BPL inactivation, cGMP production, and stability
  33. On-line prediction of the feeding phase in high-cell density cultivation of rE. coli using constructive neural networks
  34. Conjugation of Polysaccharide 6B from Streptococcus pneumoniae with Pneumococcal Surface Protein A: PspA Conformation and Its Effect on the Immune Response
  35. High cell density co-culture for production of recombinant hydrolases
  36. Intensification of high cell-density cultivations of rE. coli for production of S. pneumoniae antigenic surface protein, PspA3, using model-based adaptive control
  37. Quantification of capsular polysaccharide of Streptococcus pneumoniae serotype 14 in culture broth samples
  38. Development of production and purification processes of recombinant fragment of pneumococcal surface protein A in Escherichia coli using different carbon sources and chromatography sequences
  39. Humoral immune response of a pneumococcal conjugate vaccine: Capsular polysaccharide serotype 14—Lysine modified PspA
  40. Robust artificial intelligence tool for automatic start-up of the supplementary medium feeding in recombinant E. coli cultivations
  41. Production and purification of recombinant fragment of pneumococcal surface protein A (PspA) in Escherichia coli
  42. GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis
  43. Pneumococcal whole-cell vaccine: optimization of cell growth of unencapsulated Streptococcus pneumoniae in bioreactor using animal-free medium
  44. Protection induced by pneumococcal surface protein A (PspA) is enhanced by conjugation to a Streptococcus pneumoniae capsular polysaccharide
  45. A Heuristic Search for Optimal Parameter Values of Three Biokinetic Growth Models for Describing Batch Cultivations of Streptococcus Pneumoniae in Bioreactors
  46. An Empirical Investigation of the Use of a Neural Network Committee for Identifying the Streptococcus Pneumoniae Growth Phases in Batch Cultivations
  47. Strategies for production of polysaccharide for pneumococcal conjugate vaccine
  48. Accumulation of organic acids in cultivations of Neisseria meningitidis C
  49. Industrial purification method of the polysaccharide to be used as vaccine
  50. Optimization of medium and cultivation conditions for capsular polysaccharide production by Streptococcus pneumoniae serotype 23F
  51. An associated process for the purification of immuno globulin G, catalase, superoxide dismutase and albumin from haemolysed human placenta blood
  52. Albumin purification from human placenta
  53. Crystallization and preliminary X-ray diffraction studies of human catalase